Beth Hecht
CIK 1652410 · See Remarks · last filed 2026-06-02
Beth Hecht is a corporate insider who has filed 42 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider sold $101.0K of XERS on Jun 2, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.01M
4
42
-$1.06M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | See Remarks | 1,176,506 | $6.79 | $7.99M | -$1.06M | 27 | 2026-06-02 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 18,839 | $0.03 | $565 | $0 | 6 | 2023-06-15 |
| AYTU | Director | 9,052 | $2.15 | $19.5K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | 0 | $1.15 | $0 | $0 | 7 | 2021-03-19 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | XERS | Sell (S) | −16,667 | -$101.0K | EDGAR |
| 2026-05-01 | XERS | Sell (S) | −16,667 | -$103.8K | EDGAR |
| 2026-04-03 | XERS | Sell (S) | −16,667 | -$99.9K | EDGAR |
| 2026-03-04 | XERS | Sell (S) | −16,667 | -$104.1K | EDGAR |
| 2026-02-02 | XERS | Mixed | −64,929 | -$1.37M | EDGAR |
| 2026-01-05 | XERS | Sell (S) | −16,667 | -$123.8K | EDGAR |
| 2025-12-02 | XERS | Sell (S) | −16,667 | -$116.8K | EDGAR |
| 2025-11-13 | XERS | Sell (S) | −16,667 | -$123.3K | EDGAR |
| 2025-03-21 | XERS | Sell (S) | −40,000 | -$217.2K | EDGAR |
| 2025-02-03 | XERS | Mixed | +40,716 | -$513.7K | EDGAR |